Abstract

BackgroundMicroglia are resident myeloid cells in the CNS that are activated by infection, neuronal injury, and inflammation. Established BV2 microglial cell lines have been the primary in vitro models used to study neuroinflammation for more than a decade because they reduce the requirement of continuously maintaining cell preparations and animal experimentation models. However, doubt has recently been raised regarding the value of BV2 cell lines as a model system.MethodsWe used triplicate RNA sequencing (RNA-seq) to investigate the molecular signature of primary and BV2 microglial cell lines using two transcriptomic techniques: global transcriptomic biological triplicate RNA-seq and quantitative real-time PCR. We analyzed differentially expressed genes (DEGs) to identify transcription factor (TF) motifs (−950 to +50 bp of the 5′ upstream promoters) and epigenetic mechanisms.ResultsSequencing assessment and quality evaluation revealed that primary microglia have a distinct transcriptomic signature and express a unique cluster of transcripts in response to lipopolysaccharide. This microglial signature was not observed in BV2 microglial cell lines. Importantly, we observed that previously unidentified TFs (i.e., IRF2, IRF5, IRF8, STAT1, STAT2, and STAT5A) and the epigenetic regulators KDM1A, NSD3, and SETDB2 were significantly and selectively expressed in primary microglia (PM). Although transcriptomic alterations known to occur in BV2 microglial cell lines were identified in PM, we also observed several novel transcriptomic alterations in PM that are not frequently observed in BV2 microglial cell lines.ConclusionsCollectively, these unprecedented findings demonstrate that established BV2 microglial cell lines are probably a poor representation of PM, and we establish a resource for future studies of neuroinflammation.Electronic supplementary materialThe online version of this article (doi:10.1186/s12974-016-0644-1) contains supplementary material, which is available to authorized users.

Highlights

  • Microglia are resident myeloid cells in the central nervous system (CNS) that are activated by infection, neuronal injury, and inflammation

  • These results showed that cytokines/chemokines, antiviral genes, and IFNregulated gene (IRG) that are associated with inflammation were significantly up-regulated in response to LPS and that these changes were stronger in primary microglia (PM) than in BV2 cell lines microglia (Fig. 4a–e)

  • In summary, using RNA sequencing (RNA-seq), we compared the transcriptome changes of microglia BV2 cell lines and PM following stimulation of LPS

Read more

Summary

Introduction

Microglia are resident myeloid cells in the CNS that are activated by infection, neuronal injury, and inflammation. It has become increasingly evident that neuroinflammation, triggered by the activation of glial cells, plays a key role in many neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, and Huntington’s disease and multiple sclerosis [1, 2]. The principal resident macrophages of the brain and spinal cord, comprise 5–12 % of brain cells and act as primary effector cells. These cells play an important role in the brain’s innate immunity, neuronal homeostasis, and neuroinflammatory pathologies [2, 3]. The mechanisms that regulate microglial activation have not been completely defined

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call